PharmAbcine Inc.
Clinical-stage biotech developing human monoclonal antibodies for various diseases.
208340 | KO
Overview
Corporate Details
- ISIN(s):
- KR7208340000
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시
- Website:
- http://pharmabcine.com/
- Sector:
- Manufacturing
Description
PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-07-04 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 89.5 KB | ||
| 2024-07-03 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 29.7 KB | ||
| 2024-07-01 00:00 |
[기재정정]최대주주변경
|
Korean | 42.4 KB | ||
| 2024-07-01 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 102.6 KB | ||
| 2024-07-01 00:00 |
[기재정정]분기보고서 (2023.09)
|
Korean | 1.4 MB | ||
| 2024-07-01 00:00 |
[기재정정]사업보고서 (2023.12)
|
Korean | 1.6 MB | ||
| 2024-07-01 00:00 |
[기재정정]분기보고서 (2024.03)
|
Korean | 1.5 MB | ||
| 2024-06-28 00:00 |
증권발행결과(자율공시) (제3자배정 유상증자)
|
Korean | 6.1 KB | ||
| 2024-06-26 00:00 |
기타시장안내 (기업심사위원회 심의결과 안내)
|
Korean | 2.9 KB | ||
| 2024-06-24 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 127.6 KB | ||
| 2024-06-24 00:00 |
[기재정정]주주총회소집결의 (임시주주총회)
|
Korean | 16.7 KB | ||
| 2024-06-20 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 74.9 KB | ||
| 2024-06-17 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 77.5 KB | ||
| 2024-06-17 00:00 |
주주총회소집결의 (임시주주총회)
|
Korean | 9.2 KB | ||
| 2024-06-17 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmAbcine Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
